Community-associated methicillin-resistant Staphylococcus aureus skin infections: Advances toward identifying the key virulence factors

Current Opinion in Infectious Diseases

Volumn 21, Issue 2, 2008, Pages 147-152

  Nygaard, Tyler K ^a   DeLeo, Frank R ^b   Voyich, Jovanka M ^a,c  

^a MONTANA STATE UNIVERSITY   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c Veterinary Molecular Biology Department   (United States)

Author keywords

CA MRSA; Skin infection; Virulence

Indexed keywords

ARGININE; LEUKOCIDIN; VIRULENCE FACTOR;

BACTERIAL VIRULENCE; BACTERIUM ISOLATE; GENE SEQUENCE; GENOTYPE; GEOGRAPHY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOLECULAR MECHANICS; NONHUMAN; PROTEIN DEGRADATION; PULSED FIELD GEL ELECTROPHORESIS; REVIEW; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCUS INFECTION;

COMMUNITY-ACQUIRED INFECTIONS; HUMANS; LEUKOCIDINS; METHICILLIN RESISTANCE; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS; VIRULENCE; VIRULENCE FACTORS;

EID: 43149108342     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/QCO.0b013e3282f64819     Document Type: Review

References (40)

1. Kuehnert MJ, Kruszon-Moran D, Hill HA, et al. Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002. J Infect Dis 2006; 193:172-179.
2. Klevens RM, Morrison MA, Nadle J, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007; 298:1763-1771. This multicenter study provided a comprehensive overview of the incidence, burden and distribution of invasive MRSA disease in the United States. The study highlighted the overwhelming emergence of CA-MRSA strain USA300 and identified a potential health disparity in the observed increase in invasive MRSA infection among blacks.
3. Fitzgerald JR, Sturdevant DE, Mackie SM, et al. Evolutionary genomics of Staphylococcus aureus: insights into the origin of methicillin-resistant strains and the toxic shock syndrome epidemic. Proc Natl Acad Sci U S A 2001; 98:8821-8826.
4. Appelbaum PC. Microbiology of antibiotic resistance in Staphylococcus aureus. Clin Infect Dis 2007; 45 (Suppl 3):S165-S170.
5. Okuma K, Iwakawa K, Turnidge JD, et al. Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J Clin Microbiol 2002; 40:4289-4294.
6. Enright MC, Robinson DA, Randle G, et al. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci U S A 2002; 99:7687-7692.
7. Moroney SM, Heller LC, Arbuckle J, et al. Staphylococcal cassette chromosome mec and Panton-Valentine leukocidin characterization of methicillin-resistant Staphylococcus aureus clones. J Clin Microbiol 2007; 45:1019-1021.
8. Davis SL, Rybak MJ, Amjad M, et al. Characteristics of patients with healthcare-associated infection due to SCCmec type IVmethicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 2006; 27:1025-1031.
9. Adem PV, Montgomery CP, Husain AN, et al. Staphylococcus aureus sepsis and the Waterhouse-Friderichsen syndrome in children. N Engl J Med 2005; 353:1245-1251.
10. Kravitz GR, Dries DJ, Peterson ML, Schlievert PM. Purpura fulminans due to Staphylococcus aureus. Clin Infect Dis 2005; 40:941-947.
11. Lowy FD. Secrets of a superbug. Nat Med 2007; 13:1418-1420.
12. Miller LG, Perdreau-Remington F, Rieg G, et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 2005; 352:1445-1453.
13. Sifri CD, Park J, Helm GA, et al. Fatal brain abscess due to community-associated methicillin-resistant Staphylococcus aureus strain USA300. Clin Infect Dis 2007; 45:e113-e117.
14. Elston DM. Community-acquired methicillin-resistant Staphylococcus aureus. J Am Acad Dermatol 2007; 56:1-16.
15. Kazakova SV, Hageman JC, Matava M, et al. A clone of methicillin-resistant Staphylococcus aureus among professional football players. N Engl J Med 2005; 352:468-475.
16. Johnson JK, Khoie T, Shurland S, et al. Skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus USA300 clone. Emerg Infect Dis 2007; 13:1195-1200.
17. Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006; 355:666-674.
18. Diep BA, Carleton HA, Chang RF, et al. Roles of 34 virulence genes in the evolution of hospital- and community-associated strains of methicillin-resistant Staphylococcus aureus. J Infect Dis 2006; 193:1495-1503.
19. Diep BA, Gill SR, Chang RF, et al. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 2006; 367:731-739. This study reported the genome sequence of USA300. The study revealed that USA300 is genetically similar to MRSA strain COL and revealed the presence of arginine catabolic mobile element (ACME) in USA300. The study also emphasized how horizontal transfer from other species of staphylococci may be responsible for significant changes that enhance the increased fitness and pathogenicity of this CA-MRSA strain.
20. Goerke C, Wirtz C, Fluckiger U, Wolz C. Extensive phage dynamics in Staphylococcus aureus contributes to adaptation to the human host during infection. Mol Microbiol 2006; 61:1673-1685.
21. Tenover FC, McDougal LK, Goering RV, et al. Characterization of a strain of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States. J Clin Microbiol 2006; 44:108-118.
22. Hauck CR, Ohlsen K. Sticky connections: extracellular matrix protein recognition and integrin-mediated cellular invasion by Staphylococcus aureus. Curr Opin Microbiol 2006; 9:5-11.
23. Orwin PM, Leung DY, Donahue HL, et al. Biochemical and biological properties of Staphylococcal enterotoxin K. Infect Immun 2001; 69:360-366.
24. Foster TJ. Immune evasion by staphylococci. Nat Rev Microbiol 2005; 3:948-958.
25. Bokarewa MI, Jin T, Tarkowski A. Staphylococcus aureus: Staphylokinase. Int J Biochem Cell Biol 2006; 38:504-509.
26. Goering RV, McDougal LK, Fosheim GE, et al. Epidemiologic distribution of the arginine catabolic mobile element among selected methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates. J Clin Microbiol 2007; 45:1981-1984.
27. Makhlin J, Kofman T, Borovok I, et al. Staphylococcus aureus ArcR controls expression of the arginine deiminase operon. J Bacteriol 2007; 189:5976-5986.
28. Coulter SN, Schwan WR, Ng EY, et al. Staphylococcus aureus genetic loci impacting growth and survival in multiple infection environments. Mol Microbiol 1998; 30:393-404.
29. Voyich JM, Braughton KR, Sturdevant DE, et al. Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils. J Immunol 2005; 175:3907-3919.
30. Boyle-Vavra S, Daum RS. Community-acquired methicillin-resistant Staphylococcus aureus: the role of Panton-Valentine leukocidin. Lab Invest 2007; 87:3-9.
31. Narita S, Kaneko J, Chiba J, et al. Phage conversion of Panton-Valentine leukocidin in Staphylococcus aureus: molecular analysis of a PVL-converting phage, phiSLT. Gene 2001; 268:195-206.
32. Wardenburg JB, Bae T, Otto M, et al. Poring over pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus aureus pneumonia. Nat Med 2007; 13:1405-1406.
33. Said-Salim B, Mathema B, Braughton K, et al. Differential distribution and expression of Panton-Valentine leucocidin among community-acquired methicillin-resistant Staphylococcus aureus strains. J Clin Microbiol 2005; 43:3373-3379.
34. Voyich JM, Otto M, Mathema B, et al. Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J Infect Dis 2006; 194:1761-1770. This study used human neutrophil assays and animal skin and sepsis models to analyze virulence of Panton-Valentine leukocidin (PVL)-positive and PVL-negative CA-MRSA strains as well as isogenic deletion knockouts of lukS/F-PV (endoding PVL) in strains USA300 and USA400. Findings from the study demonstrate that PVL is not the major virulence determinant of CA-MRSA.
35. Wang R, Braughton KR, Kretschmer D, et al. Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA. Nat Med 2007; 13:1510-1514. This study linked production of cytolytic peptides (PSMs) with enhanced virulence of CA-MRSA. CA-MRSA strains showed increased production of PSMs and isogenic deletion of PSMα (in strains USA400 and USA300) significantly attenuated skin lesions in mice. This study also demonstrated that wild-type PSMs caused significant lysis of human neutrophils.
36. Cheung AL, Bayer AS, Zhang G, et al. Regulation of virulence determinants in vitro and in vivo in Staphylococcus aureus. FEMS Immunol Med Microbiol 2004; 40:1-9.
37. Park J, Jagasia R, Kaufmann GF, et al. Infection control by antibody disruption of bacterial quorum sensing signaling. Chem Biol 2007; 14:1119-1127. This study explored interfering with quorum sensing signally and subsequent virulence factor production as a means to ameliorate staphylococcal virulence. The study used an antibody specific to the autoinducing peptide (AIP) of the accessory gene regulator agr to demonstrate that interfering with the agr signaling mechanism disrupts normal agr function rendering S. aureus less virulent. This observation advances the search for potential novel antistaphylococcal therapeutics.
38. Wright JS III, Jin R, Novick RP. Transient interference with staphylococcal quorum sensing blocks abscess formation. Proc Natl Acad Sci U S A 2005; 102:1691-1696.
39. Novick RP. Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol Microbiol 2003; 48:1429-1449.
40. Xiong YQ, Willard J, Yeaman MR, et al. Regulation of Staphylococcus aureus alpha-toxin gene (hla) expression by agr, sarA, and sae in vitro and in experimental infective endocarditis. J Infect Dis 2006; 194:1267-1275. This study investigated regulation of hla expression in vitro and in vivo using a rabbit experimental infective endocarditis model. Results demonstrate the complexity of staphylococcal regulation of virulence and highlights differences between in-vitro and in-vivo regulation of virulence.